Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRAVO 3: Bivalirudin vs Heparin in TAVR
NCT01651780Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Oct 2012
- Primary completion
- Jun 2015
- Modality
- Peptides, Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of bivalirudin in aortic stenosis (AS), sponsored by The Medicines Company. Started Oct 2012; status: completed.
02
Drugs
bivalirudin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT01651780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01651780.